The Effects of Resistance Exercise and Protein Supplementation in Hemodialysis Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

19 participants

Study Classification

INTERVENTIONAL

Study Start Date

2005-04-30

Study Completion Date

2007-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study is to determine how protein supplementation, with or without exercise, affects functional capacity, strength, body composition, and physical activity in hemodialysis patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Effects of Protein Supplementation and Resistance Exercise in Hemodialysis Patients

NCT00179140

End Stage Renal Disease

COMPLETED PHASE2

Resistance Training and Diet in Patients With Chronic Renal Failure

NCT00018317

Kidney Failure, Chronic

COMPLETED NA

Protein and Exercise Training in Chronic KIDNEY Disease

NCT05482243

Kidney Diseases Muscle Loss

COMPLETED NA

Effect of Exercise and Protein Supplementation on Muscle Function in Patients With Hemodialysis

NCT04927208

Sarcopenia

COMPLETED NA

Exercise and Nutritional Intervention for Deconditioned Older Adults

NCT01115530

Muscle Weakness

WITHDRAWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

End Stage Renal Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

only protein supplementation

Group Type ACTIVE_COMPARATOR

nutritional supplementation

Intervention Type DRUG

oral administration of 2 cans of protein supplement (lactose-free formula that contains a total of 960 kilocalories: 132.8 kilocalories from protein, 412.8 kilocalories from carbohydrates, and 412.8 kilocalories from fat); every other day, 3 days per week, for 6 months

2

protein supplementation plus exercise

Group Type ACTIVE_COMPARATOR

nutritional supplementation

Intervention Type DRUG

oral administration of 2 cans of protein supplement (lactose-free formula that contains a total of 960 kilocalories: 132.8 kilocalories from protein, 412.8 kilocalories from carbohydrates, and 412.8 kilocalories from fat); every other day, 3 days per week, for 6 months

exercise

Intervention Type BEHAVIORAL

leg press exercise; every other day, 3 days per week, for 6 months

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

nutritional supplementation

oral administration of 2 cans of protein supplement (lactose-free formula that contains a total of 960 kilocalories: 132.8 kilocalories from protein, 412.8 kilocalories from carbohydrates, and 412.8 kilocalories from fat); every other day, 3 days per week, for 6 months

Intervention Type DRUG

exercise

leg press exercise; every other day, 3 days per week, for 6 months

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* On hemodialysis for more than 3 months, on a thrice weekly hemodialysis program;
* Adequately dialyzed (Kt/V ≥ 1.2).
* Age ≥ 18 years old.

Exclusion Criteria

* Patients unable to perform exercise due to cardiovascular disease, osteoarthritis, etc., as determined by the PI and the primary physician of the subject.
* Pregnant women.
* Patients hospitalized within the last month prior to the study.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No